Chronic resveratrol treatment restores vascular responsiveness of cerebral arterioles in type 1 diabetic rats

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 301, Issue 3, 2011, Pages

  Arrick, Denise M ^a   Sun, Hong ^b   Patel, Kaushik P ^b   Mayhan, William G ^a  

^a Louisiana State University School of Medicine Shreveport   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Adenosine 5' diphosphate; Brain; N methyl D aspartic acid; Nitroglycerin; Oxidative stress; Superoxide

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; MANGANESE SUPEROXIDE DISMUTASE; NEURONAL NITRIC OXIDE SYNTHASE; RESVERATROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIOLE; ARTICLE; BLOOD VESSEL REACTIVITY; BRAIN TISSUE; CONTROLLED STUDY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; VASODILATATION; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; ANIMALS; ANTIOXIDANTS; ARTERIOLES; BLOTTING, WESTERN; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; PIA MATER; RATS; RATS, SPRAGUE-DAWLEY; STILBENES; SUPEROXIDE DISMUTASE; SUPEROXIDES; VASODILATION; VASODILATOR AGENTS;

EID: 80052322329     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00312.2011     Document Type: Article

References (58)

1. Arrick DM, Sharpe GM, Sun H, Mayhan WG. Diabetes-induced cerebrovascular dysfunction: role of poly(ADP-ribose) polymerase. Microvasc Res 73: 1-6, 2007.
2. Arvanitakis Z, Wilson RS, Bienias JL, Evans DA, Bennett DA. Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol 61: 661-666, 2004.
3. Ayajiki K, Okamura T, Toda N. Involvement of nitric oxide in endothelium-dependent, phasic relaxation caused by histamine in monkey cerebral arteries. Jpn J Pharmacol 60: 357-362, 1992.
4. Baird TA, Parsons MW, Barber PA, Butcher KS, Desmond PM, Tress BM, Colman PG, Jerums G, Chambers BR, Davis SM. The influence of diabetes mellitus and hyperglycaemia on stroke incidence and outcome. J Clin Neurosci 9: 618-626, 2002.
5. Bertelli AA, Giovannini L, Bernini W, Migliori M, Fregoni M, Bavaresco L, Bertelli A. Antiplatelet activity of cis-resveratrol. Drugs Exp Clin Res 22: 61-63, 1996.
6. Bertelli AA, Giovannini L, Giannessi D, Migliori M, Bernini W, Fregoni M, Bertelli A. Antiplatelet activity of synthetic and natural resveratrol in red wine. Int J Tissue React 17: 1-3, 1995.
7. Bertelli AA, Migliori M, Panichi V, Origlia N, Filippi C, Das DK, Giovannini L. Resveratrol, a component of wine and grapes, in the prevention of kidney disease. Ann NY Acad Sci 957: 230-238, 2002.
8. Bradamante S, Barenghi L, Piccinini F, Bertelli AA, De Jonge R, Beemster P, De Jong JW. Resveratrol provides late-phase cardioprotection by means of a nitric oxide-and adenosine-mediated mechanism. Eur J Pharmacol 465: 115-123, 2003.
9. Brayden JE. Hyperpolarization and relaxation of resistance arteries in response to adenosine diphosphate. Circ Res 69: 1415-1420, 1991.
10. Chrissobolis S, Ziogas J, Chu Y, Faraci FM, Sobey CG. Role of inwardly rectifying K channels in K-induced cerebral vasodilatation in vivo. Am J Physiol Heart Circ Physiol 279: H2704-H2712, 2000.
11. Coppey LJ, Gellett JS, Davidson EP, Yorek MA. Preventing superoxide formation in epineurial arterioles of the sciatic nerve from diabetic rats restores endothelium-dependent vasodilation. Free Radic Res 37: 33-40, 2003.
12. Creager MA, Luscher TF, Cosentino F, Beckman JA. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I. Circulation 108: 1527-1532, 2003.
13. Csiszar A, Labinskyy N, Pinto JT, Ballabh P, Zhang H, Losonczy G, Pearson K, de Cabo R, Pacher P, Zhang C, Ungvari Z. Resveratrol induces mitochondrial biogenesis in endothelial cells. Am J Physiol Heart Circ Physiol 297: H13-H20, 2009.
14. Das S, Das DK. Anti-inflammatory responses of resveratrol. Inflamm Allergy Drug Targets 6: 168-173, 2007.
15. Faraci FM. Role of endothelium-derived relaxing factor in cerebral circulation: Large arteries vs. microcirculation. Am J Physiol Heart Circ Physiol 261: H1038-H1042, 1991.
16. Faraci FM, Breese KR. Nitric oxide mediates vasodilatation in response to activation of N-methyl-D-aspartate receptors in brain. Circ Res 72: 476-480, 1993.
17. Faraci FM, Breese KR, Heistad DD. Responses of cerebral arterioles to kainate. Stroke 25: 2080-2084, 1994.
18. Faraci FM, Brian JE. 7-Nitroindazole inhibits brain nitric oxide synthase and cerebral vasodilatation in response to N-methyl-D-aspartate. Stroke 26: 2172-2176, 1995.
19. Faraci FM, Heistad DD. Role of ATP-sensitive potassium channels in the basilar artery. Am J Physiol Heart Circ Physiol 264: H8-H13, 1993.
20. Fulgenzi A, Bertelli AA, Magni E, Ferrero E, Ferrero ME. In vivo inhibition of TNFalpha-induced vascular permeability by resveratrol. Transplant Proc 33: 2341-2343, 2001.
21. Hadi HA, Suwaidi JA. Endothelial dysfunction in diabetes mellitus. Vasc Health Risk Manag 3: 853-876, 2007.
22. Hasko G, Pacher P. Endothelial Nrf2 activation: a new target for resveratrol? Am J Physiol Heart Circ Physiol 299: H10-H12, 2010.
23. Hattori Y, Kawasaki H, Abe K, Kanno M. Superoxide dismutase recovers altered endothelium-dependent relaxation in diabetic rat aorta. Am J Physiol Heart Circ Physiol 261: H1086-H1094, 1991.
24. Ho SM. Estrogens and anti-estrogens: key mediators of prostate carcinogenesis and new therapeutic candidates. J Cell Biochem 91: 491-503, 2004.
25. Laing SP, Swerdlow AJ, Carpenter LM, Slater SD, Burden AC, Botha JL, Morris AD, Waugh NR, Gatling W, Gale EA, Patterson CC, Qiao Z, Keen H. Mortality from cerebrovascular disease in a cohort of 23 000 patients with insulin-treated diabetes. Stroke 34: 418-421, 2003.
26. Luscher TF, Creager MA, Beckman JA, Cosentino F. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part II. Circulation 108: 1655-1661, 2003.
27. Marrelli SP, Khorovets A, Johnson TD, Childres WF, Bryan RM Jr. P2 purinoceptor-mediated dilations in the rat middle cerebral artery after ischemia-reperfusion. Am J Physiol Heart Circ Physiol 276: H33-H41, 1999.
28. Mayhan WG, Arrick DM, Sharpe GM, Patel KP, Sun H. Inhibition of NAD(P)H oxidase alleviates impaired NOS-dependent responses of pial arterioles in type 1 diabetes mellitus. Microcirculation 13: 567-575, 2006.
29. Mayhan WG. Impairment of endothelium-dependent dilatation of cerebral arterioles during diabetes mellitus. Am J Physiol Heart Circ Physiol 256: H621-H625, 1989.
30. Mayhan WG. Endothelium-dependent responses of cerebral arterioles to adenosine 5'-diphosphate. J Vasc Res 29: 353-358, 1992.
31. Mayhan WG. Impairment of endothelium-dependent dilatation of the basilar artery during diabetes mellitus. Brain Res 580: 297-302, 1992.
32. Mayhan WG. Superoxide dismutase partially restores impaired dilatation of the basilar artery during diabetes mellitus. Brain Res 760: 204-209, 1997.
33. Mayhan WG, Heistad DD. Permeability of blood-brain barrier to various sized molecules. Am J Physiol Heart Circ Physiol 248: H712-H718, 1985.
34. Meeran SM, Katiyar SK. Cell cycle control as a basis for cancer chemoprevention through dietary agents. Front Biosci 13: 2191-2202, 2008.
35. Mogi M, Horiuchi M. Neurovascular coupling in cognitive impairment associated with diabetes mellitus. Circ J 25: 1042-1048, 2011.
36. Nassar T, Kadery B, Lotan C, Da'as N, Kleinman Y, Haj-Yehia A. Effects of the superoxide dismutase-mimetic compound tempol on endothelial dysfunction in streptozotocin-induced diabetic rats. Eur J Pharmacol 436: 111-118, 2002.
37. Nesto RW. Correlation between cardiovascular disease and diabetes mellitus: current concepts. Am J Med 116, Suppl 5A: 11S-22S, 2004.
38. Ohishi K, Carmines PK. Superoxide dismutase restores the influence of nitric oxide on renal arterioles in diabetes mellitus. J Am Soc Nephrol 5: 1559-1566, 1995.
39. Phillips SA, Sylvester FA, Frisbee JC. Oxidant stress and constrictor reactivity impair cerebral artery dilation in obese Zucker rats. Am J Physiol Regul Integr Comp Physiol 288: R522-R530, 2005.
40. Pieper GM, Mei DA, Langenstroer P, O'Rourke ST. Bioassay of endothelium-derived relaxing factor in diabetic rat aorta. Am J Physiol Heart Circ Physiol 263: H676-H680, 1992.
41. Roghani M, Baluchnejadmojarad T. Mechanisms underlying vascular effects of chronic resveratrol in streptozotocin-diabetic rats. Phytother Res 10: 1-7, 2009.
42. Schwaninger RM, Sun H, Mayhan WG. Impaired nitric oxide synthasedependent dilatation of cerebral arterioles in type II diabetic rats. Life Sci 73: 3415-3425, 2003.
43. Sharma S, Anjaneyulu M, Kulkarni SK, Chopra K. Resveratrol, a polyphenolic phytoalexin, attenuates diabetic nephropathy in rats. Pharmacology 76: 69-75, 2006.
44. Silan C. The effects of chronic resveratrol treatment on vascular responsiveness of streptozotocin-induced diabetic rats. Biol Pharm Bull 31: 897-902, 2008.
45. Silan C, Uzun O, Comunoglu NU, Gokcen S, Bedirhan S, Cengiz M. Gentamicin-induced nephrotoxicity in rats ameliorated and healing effects of resveratrol. Biol Pharm Bull 30: 79-83, 2007.
46. Su HC, Hung LM, Chen JK. Resveratrol, a red wine antioxidant, possesses an insulin-like effect in streptozotocin-induced diabetic rats. Am J Physiol Endocrinol Metab 290: E1339-E1346, 2006.
47. Sulaiman M, Matta MJ, Sunderesan NR, Gupta MP, Periasamy M, Gupta M. Resveratrol, an activator of SIRT1, upregulates sarcoplasmic calcium ATPase and improves cardiac function in diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol 298: H833-H843, 2010.
48. Sun H, Molacek E, Zheng H, Fang Q, Patel KP, Mayhan WG. Alcohol-induced impairment of neuronal nitric oxide synthase (nNOS)-dependent dilation of cerebral arterioles: role of NAD(P)H oxidase. J Mol Cell Cardiol 40: 321-328, 2006.
49. Sun H, Zheng H, Molacek E, Fang Q, Patel KP, Mayhan WG. Role of NAD(P)H oxidase in alcohol-induced impairment of endothelial nitric oxide synthase-dependent dilation of cerebral arterioles. Stroke 37: 495-500, 2006.
50. Sun H, Patel KP, Mayhan WG. Impairment of neuronal nitric oxide synthase-dependent dilatation of cerebral arterioles during chronic alcohol consumption. Alcohol Clin Exp Res 26: 663-670, 2002.
51. Taguchi H, Heistad DD, Kitazono T, Faraci FM. Dilatation of cerebral arterioles in response to activation of adenylate cyclase is dependent on activation of Ca2-dependent K channels. Circ Res 76: 1057-1062, 1995.
52. Tarquini B, Perfetto F, Tarquini R, Cornelissen G, Halberg F. Endothelin-1's chronome indicates diabetic and vascular disease chronorisk. Peptides 18: 119-132, 1997.
53. Thirunavukkarasu M, Penumathsa SV, Koneru S, Juhasz B, Zhan L, Otani H, Bagchi D, Das DK, Maulik N. Resveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: role of nitric oxide, thioredoxin, and heme oxygenase. Free Radic Biol Med 43: 720-729, 2007.
54. Ungvari Z, Labinskyy N, Mukhopadhyay P, Pinto JT, Bagi Z, Ballabh P, Zhang C, Pacher P, Csiszar A. Resveratrol attenuates mitochondrial oxidative stress in coronary arterial endothelial cells. Am J Physiol Heart Circ Physiol 297: H1876-H1881, 2009.
55. Vilar S, Quezada E, Santana L, Uriarte E, Yanez M, Fraiz N, Alcaide C, Cano E, Orallo F. Design, synthesis, and vasorelaxant and platelet antiaggregatory activities of coumarin-resveratrol hybrids. Bioorg Med Chem Lett 16: 257-261, 2006.
56. You J, Johnson TD, Marrelli SP, Mombouli JV, Bryan RM. P2u receptor-mediated release of endothelium-derived relaxing factor/nitric oxide and endothelium-derived hyperpolarizing factor from cerebrovascular endothelium in rats. Stroke 30: 1125-1133, 1999.
57. Zhang H, Zhang J, Ungvari Z, Zhang C. Resveratrol improves endothelial function: role of TNFa and vascular oxidative stress. Arterioscler Thromb Vasc Biol 29: 1164-1171, 2009.
58. Zini R, Morin C, Bertelli A, Bertelli AA, Tillement JP. Effects of resveratrol on the rat brain respiratory chain. Drugs Exp Clin Res 25: 87-97, 1999.